Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,661,417 papers from all fields of science
Search
Sign In
Create Free Account
Conventional Leiomyosarcoma
Known as:
Classic Leiomyosarcoma
An uncommon, aggressive malignant smooth muscle neoplasm. It is characterized by the presence of atypical large spindle or round cells, nuclear…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
15 relations
Coagulative necrosis
Connective Tissue Cells
Connective and Soft Tissue
Epithelial Cells
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Leiomyosarcoma FNCLCC G3 pT2B of broad ligament adherent to right oviduct - case report with molecular profiling.
A. Wincewicz
,
A. Kowalik
,
Sebastian Zięba
,
S. Góźdź
,
Martyna Woltanowska
Romanian journal of morphology and embryology…
2016
Corpus ID: 1643312
Here we present a report of 61-year-old female patient. Uterus with left appendages was removed together with clinically tagged…
Expand
Review
2015
Review
2015
Pleomorphic leiomyosarcoma with a dedifferentiation-like appearance in the kidney: case report and literature review
S. Tajima
,
M. Waki
,
M. Fukuyama
Medical Molecular Morphology
2015
Corpus ID: 1391639
Although primary leiomyosarcoma of the kidney is extremely rare, it is the most common sarcoma of the kidney. Leiomyosarcoma with…
Expand
Review
2010
Review
2010
Leiomyosarcoma with osteoclast-like giant cells of the uterus: a case report and literature review.
K. Sukpan
,
S. Khunamornpong
,
P. Suprasert
,
S. Siriaunkgul
Journal of the Medical Association of Thailand…
2010
Corpus ID: 1463494
The presence of osteoclast-like giant cells (OGC) has been reported as a rare and distinct feature in uterine leiomyosarcoma. To…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE